Hong Kong scholars found that in HBV-HCC, TAM suppress tumor T-cell infiltration and regulate the immunosuppressive environment through TIGIT-NECTIN2 interactions (Ho et al., 2021). The gene discussed is NECTIN2; the disease is hepatocellular carcinoma.